Clinical trial Recruiting at 1 site Interventional Ages 18 to 42 Women only

Comparing two methods for assessing fertility in women

Official title: Is, in Infertile Women Undergoing a Basic Fertility Work-up, Tubal Flushing With Oil-based Contrast Medium During Hysterosalpingography (HSG) Cost-effective Compared to Tubal Flushing by Hysterosalpingo-foam Sonography (HyFoSy)?

Run by Amsterdam UMC, location VUmc · NCT05882188 · Data updated 2026-11-12

This study is testing whether a common fertility test using oil-based contrast can help women have more babies compared to a foam-based test.

Quick facts

Study typeInterventional
Ages18 Years to 42 Years
SexWomen only
Enrollment1102 (estimated)
SponsorAmsterdam UMC, location VUmc
Academic / other
Locations1 site (Amsterdam)
StatusRecruiting
StartedSeptember 22, 2023
Main results expectedDecember 1, 2026
Study endsJune 1, 2027
Registry record updatedApril 24, 2024
Trial IDNCT05882188 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include infertile women or those with oligo-or anovulation who require tubal patency testing.

Probably not a fit

Patients with severe male factor infertility or known reproductive tract neoplasia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness and cost-effectiveness of two methods for assessing tubal patency in women undergoing fertility work-up: hysterosalpingography (HSG) with oil-based contrast and hysterosalpingo-foam sonography (HyFoSy) with ExEm Foam. The main objective is to determine whether HSG leads to more live births compared to HyFoSy. The study is designed as a multicenter randomized controlled trial, aiming to provide insights into the safety and economic implications of both approaches. By comparing these methods, the study seeks to enhance fertility outcomes and reduce the need for expensive fertility treatments.

Why it matters

Potential benefit: If successful, this study could lead to higher live birth rates for women undergoing fertility assessments.

How similar studies have gone: Previous studies have shown that oil-based contrast during HSG may lead to better pregnancy outcomes, but the comparison with HyFoSy is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Infertile women or women with oligo-or anovulation
* Indication for tubal patency testing during the fertility work-up
* Sufficient understanding of the Dutch or English language
* Signed informed consent

Exclusion Criteria:

* Severe male factor with a total motile sperm count \<3x106ml (pre-washed)
* Known contrast (iodine) allergy
* Women who have had a gynecologic procedure within the last 30 days
* Women with known or suspected reproductive tract neoplasia

Where it's running

  • AmsterdamUMC
    Amsterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.